What is the latest research on platelet‑rich plasma (PRP) for hair loss?

Latest Research on Platelet-Rich Plasma for Hair Loss

Based on the most recent 2025 guidelines, PRP is a safe and effective treatment for androgenetic alopecia (AGA) that significantly increases hair density and reduces hair loss, though it does not meaningfully improve hair thickness. 1

Key Evidence and Recommendations

Efficacy Profile

The 2025 Periodontology 2000 guidelines synthesize extensive evidence showing that PRP demonstrates:

• Significant improvements in hair density (31% increase with non-activated PRP) 1
• Increased hair follicle proliferative activity and improved hair morphology 1
• Reduced hair loss across multiple studies 1
• High patient satisfaction (mean score 7.42/10) 1

A 2025 systematic review and meta-analysis of 43 randomized controlled trials (1,877 participants) confirms that activated PRP effectively increases hair density and minimizes recurrence compared to placebo, though PRP did not significantly affect hair thickness 2. This aligns with the guideline consensus that while hair density improves substantially, thickness changes remain inconsistent.

Critical Treatment Protocol (Indian Association of Dermatologists Framework)

The standardized protocol based on 30 evaluated articles recommends: 1

• Preparation: Manual double-spin method
• Platelet concentration: 1 to 1.5 million platelets per μL
• Dosing: 5-7 mL PRP total, using 0.05 to 0.1 mL/cm²
• Injection technique: 30G × 4mm needles, 90-degree angle, 2-4mm depth, injections 1cm apart
• Treatment phase: 3-5 sessions, 1 month intervals (or every 4-6 weeks)
• Maintenance phase: 1 session every 6 months after initial year
• Activation: NOT required (non-activated PRP shows superior results) 1

Combination Therapy Superiority

PRP combined with 5% minoxidil is more effective than either treatment alone, showing:

• Hair density increased 1.74 times
• Hair diameter increased 14.3 times
• Telogen hair proportion decreased 9.3 times 1

The guidelines explicitly state: "For best results it is advisable to apply a complex combined therapy protocol as early as possible" 1. This means initiating PRP + minoxidil (and finasteride/spironolactone when appropriate) at the earliest signs of AGA rather than waiting for progression.

Platelet-Rich Fibrin (PRF) as Alternative

PRF is emerging as a potentially superior option to PRP with theoretical advantages:

• Safe, time and cost-effective 1
• Particularly valuable in mild AGA cases 1
• Shows clinical efficacy across all ages and genders 1
• Beneficial as adjuvant to hair transplantation 1

However, the guidelines acknowledge that PRF protocols need standardization and direct comparative studies with PRP are lacking 1.

Gender and Severity Considerations

Recent 2024-2025 research highlights important nuances:

• Female pattern hair loss: A 2024 meta-analysis of 21 studies (628 women) confirms PRP significantly enhances hair density and thickness with favorable safety profile, though effects vary with dosage, injection duration, and ethnicity 3
• Severity matters: More severe grades of AGA showed greater improvement with PRF treatment 1
• Early intervention: 25% improvement in hair density at 2 months predicts sustained response at 6 months 1

Hair Transplantation Adjunct

PRP significantly improves hair transplant outcomes when used as adjuvant therapy:

• Improved follicle survival rates 4
• Enhanced follicle growth rates 4
• Increased hair strength 4
• Better graft retention 1

Protocol: Split scalp injection at month 0,1, and 3 after transplantation 1

Critical Limitations and Caveats

The evidence remains controversial despite growing support 1. The 2025 guidelines explicitly acknowledge:

• High variability in study designs: Preparations, protocols, and treatment intervals differ substantially
• Inadequate follow-up periods: Many patients not assessed long enough to determine durability
• Lack of standardization: Optimal number of treatments, intervals, and PRP amounts still undefined 1
• No hair thickness benefit: Despite improvements in density, thickness changes are not significant 2

Safety Profile

Adverse effects are generally mild and transient:

• Localized pain, bleeding, itching 5
• No significant difference in pain/discomfort versus controls 3
• Non-activated PRP associated with higher frequency of adverse effects compared to activated PRP 2

This creates a clinical dilemma: non-activated PRP shows better efficacy but potentially more side effects, while activated PRP has fewer adverse events but lower efficacy 1, 2.

Practical Clinical Algorithm

For new AGA patients:

1. Initiate combination therapy early: PRP (non-activated) + 5% minoxidil ± finasteride/spironolactone
2. Treatment phase: 3 sessions, 1 month apart
3. Assess response at 2 months: ≥25% improvement in hair density predicts sustained benefit
4. Complete initial year: Evaluate after 12 months
5. Maintenance: Every 6 months if responsive

For hair transplant candidates:

• Pre-treatment with PRP 7 days prior
• Soak follicles in PRP during surgery
• Post-operative injections at months 0,1, and 3

For mild cases or cost-conscious patients:

• Consider PRF as alternative (potentially more cost-effective) 1

The evidence strongly supports PRP as a legitimate treatment option for AGA, particularly when combined with conventional therapies and initiated early in disease course. However, patients must understand that improvements primarily affect hair density and count rather than individual hair thickness, and maintenance therapy is required to sustain benefits.